Roflumilast CAS 162401-32-3 Assay 99.0 ~ 101.0% API
Ruifu Chemical Supply Roflumilast Intermediates:
Roflumilast CAS 162401-32-3
Tom ntej: 4-Amino-3,5-Dichloropyridine CAS 22889-78-7
Tshuaj npe | Roflumilast |
Synonyms | 3-(Cyclopropylmethoxy)-N-(3,5-Dichloropyridin-4-yl)-4-(Ddifluoromethoxy)benzamide |
CAS Nr | 162401-32-3 |
CAT Number | Qauv TSIS MUAJ: RF-PI2075 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C17H14Cl2F2N2O3 |
Molecular Luj | 403.21 Nws |
Qhov ntom | 1.471 ± 0.060 g / cm3 |
rhiab heev | Thaum tshav kub kub Sensitive |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb los yog Yuav luag Dawb Crystalline Hmoov |
Solubility | Dawb soluble nyob rau hauv acetone, sparingly soluble nyob rau hauv acetronitrile, me ntsis insoluble nyob rau hauv anhydrous ethanol, xyaum insoluble nyob rau hauv dej |
Melting Point | 157.0 ~ 162.0 ℃ |
Poob rau ziab | <0.50% |
Residue ntawm Ignition | ≤0.10% |
Hnyav Hlau | ≤10ppm |
Chloride | ≤ 0.01% |
Identification A. UV | Lub wavelength ntawm qhov siab tshaj plaws nqus yuav tsum yog 213 ~ 251nm |
Identification B. IR | IR absorption spectrum ntawm cov qauv sib raug rau qhov kev siv ib qho |
Kev txheeb xyuas C. | Nws qhia txog cov tshuaj Fluoride |
Yam khoom muaj feem | |
Ib leeg Impurity | ≤0.10% |
Tag nrho cov impurities | <0.50% |
Residual Solvents | |
Tert-Butanol | <0.10% |
Tetrahydrofuran | <0.072% |
Toluene | <0.089% |
N, N-Dimethylformamide | <0.088% |
Assay | 99.0 ~ 101.0% (Xaiv ntawm Kev Qhuav Qhuav) |
Test Standard | Enterprise Standard |
Kev siv | API;COPD |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo
Roflumilast (CAS: 162401-32-3) yog ib qho kev xaiv qhov ncauj phosphodiesterase-4 (PDE-4) inhibitor thiab benzamide compound.Nws tau tsim los ntawm German tuam txhab Altana hauv xyoo 1993 thiab yog tib lub qhov ncauj PDE-4 inhibitor siv los kho cov kab mob ua pa uas pom zoo rau kev muag khoom.Roflumilast yog thawj cov tshuaj ntawm nws cov hom phiaj rau cov mob hnyav mob ntsws obstructive pulmonary (COPD), thiab nws kuj yog thawj cov tshuaj tiv thaiv kab mob hauv qhov ncauj tshwj xeeb tsim rau cov neeg mob COPD.Nws cov khoom tshwj xeeb tuaj yeem pab tswj COPD: thaum siv ua ke nrog cov tshuaj bronchodilators los kho cov neeg mob COPD hnyav heev, Roflumilast tuaj yeem muaj qhov zoo ntawm kev txo cov tsos mob thiab kev tsis zoo, yog li ua rau nws yog thawj cov tshuaj uas tsom rau cov neeg mob rov qab deteriorating phenotype-spAecific COPD. thiab huab cua loj heev cuam tshuam cuam tshuam nrog hnoos ntev thiab ntau phlegm.Dhau li ntawm kev kho mob COPD hnyav, Roflumilast tseem tuaj yeem siv los tiv thaiv thiab kho tsiaj cov kab mob ua pa, ua pa ntau dhau ntawm cov hnoos qeev, mob ntsws asthmatic, thiab mob ntsws bronchitis thiab huab cua sacculitis nrog rau kev ua pa txawv txav.